Aker BioMarine ASA (OSL:AKBM)

Market Cap	7.29B
Revenue (ttm)	2.14B
Net Income (ttm)	-365.56M
Shares Out	87.70M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	33.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,203
Average Volume	21,420
Open	81.60
Previous Close	83.10
Day's Range	81.60 - 84.00
52-Week Range	43.65 - 94.30
Beta	0.36
RSI	40.81
Earnings Date	Oct 31, 2025

About Aker BioMarine ASA

Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name. ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 249
• Stock Exchange: Oslo Børs
• Ticker Symbol: AKBM

Financial Performance

Financial numbers in USD